Cargando…

Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans

Candida dubliniensis, an emerging fungal pathogen, is the closest known species to the established pathogenic species Candida albicans. Despite the fact that these two species share > 80% genome sequence identity, they exhibit distinct properties such as less hyphal growth, reduced pathogenicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Heitman, Joseph, Chen, Ying-Lien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376044/
https://www.ncbi.nlm.nih.gov/pubmed/22808313
http://dx.doi.org/10.4161/cib.18833
_version_ 1782235796337590272
author Zhang, Jing
Heitman, Joseph
Chen, Ying-Lien
author_facet Zhang, Jing
Heitman, Joseph
Chen, Ying-Lien
author_sort Zhang, Jing
collection PubMed
description Candida dubliniensis, an emerging fungal pathogen, is the closest known species to the established pathogenic species Candida albicans. Despite the fact that these two species share > 80% genome sequence identity, they exhibit distinct properties such as less hyphal growth, reduced pathogenicity and increased sensitivity to sodium stress and elevated temperatures in C. dubliniensis compared with C. albicans. It is, however, largely unknown whether signaling pathways are conserved in the two Candida species. Calcineurin signaling is known to be required for hyphal growth in Cryptococcus neoformans and Aspergillus fumigatus but remains elusive in C. albicans. Our recent study showed that calcineurin plays a clearly demonstrable role in controlling hyphal growth, drug tolerance and virulence in C. dubliniensis. Here, we extend our studies and show that calcineurin is conserved in controlling endoplasmic reticulum stress but distinct in governing pH homeostasis. Furthermore, we demonstrate that azole or echinocandin drugs in combination with the calcineurin inhibitor FK506 exhibit a synergistic effect against C. dubliniensis wild-type and echinocandin-resistant strains. The involvement of calcineurin in a variety of fungal virulence attributes and as a target for fungicidal synergism with azoles and echinocandins highlights the potential of combination therapy with calcineurin inhibitors for treating Candida infections.
format Online
Article
Text
id pubmed-3376044
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-33760442012-07-17 Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans Zhang, Jing Heitman, Joseph Chen, Ying-Lien Commun Integr Biol Short Communication Candida dubliniensis, an emerging fungal pathogen, is the closest known species to the established pathogenic species Candida albicans. Despite the fact that these two species share > 80% genome sequence identity, they exhibit distinct properties such as less hyphal growth, reduced pathogenicity and increased sensitivity to sodium stress and elevated temperatures in C. dubliniensis compared with C. albicans. It is, however, largely unknown whether signaling pathways are conserved in the two Candida species. Calcineurin signaling is known to be required for hyphal growth in Cryptococcus neoformans and Aspergillus fumigatus but remains elusive in C. albicans. Our recent study showed that calcineurin plays a clearly demonstrable role in controlling hyphal growth, drug tolerance and virulence in C. dubliniensis. Here, we extend our studies and show that calcineurin is conserved in controlling endoplasmic reticulum stress but distinct in governing pH homeostasis. Furthermore, we demonstrate that azole or echinocandin drugs in combination with the calcineurin inhibitor FK506 exhibit a synergistic effect against C. dubliniensis wild-type and echinocandin-resistant strains. The involvement of calcineurin in a variety of fungal virulence attributes and as a target for fungicidal synergism with azoles and echinocandins highlights the potential of combination therapy with calcineurin inhibitors for treating Candida infections. Landes Bioscience 2012-03-01 /pmc/articles/PMC3376044/ /pubmed/22808313 http://dx.doi.org/10.4161/cib.18833 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Short Communication
Zhang, Jing
Heitman, Joseph
Chen, Ying-Lien
Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans
title Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans
title_full Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans
title_fullStr Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans
title_full_unstemmed Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans
title_short Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans
title_sort comparative analysis of calcineurin signaling between candida dubliniensis and candida albicans
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376044/
https://www.ncbi.nlm.nih.gov/pubmed/22808313
http://dx.doi.org/10.4161/cib.18833
work_keys_str_mv AT zhangjing comparativeanalysisofcalcineurinsignalingbetweencandidadubliniensisandcandidaalbicans
AT heitmanjoseph comparativeanalysisofcalcineurinsignalingbetweencandidadubliniensisandcandidaalbicans
AT chenyinglien comparativeanalysisofcalcineurinsignalingbetweencandidadubliniensisandcandidaalbicans